Targeting the tumour microenvironment in platinum-resistant ovarian cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the tumour microenvironment in platinum-resistant ovarian cancer
Authors
Keywords
Ovarian cancer, Tumour microenvironment, Platinum resistance, Immune cells, Metabolism
Journal
SEMINARS IN CANCER BIOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-02-18
DOI
10.1016/j.semcancer.2021.02.007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance
- (2020) Abir Mukherjee et al. CANCER RESEARCH
- Ovarian cancer‐associated mesothelial cells induce acquired platinum‐resistance in peritoneal metastasis via the FN1/Akt signaling pathway
- (2020) Masato Yoshihara et al. INTERNATIONAL JOURNAL OF CANCER
- The Pentose Phosphate Pathway and Its Involvement in Cisplatin Resistance
- (2020) Isabella Giacomini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer
- (2020) Anders Etzerodt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Lactic Acidosis Together with GM-CSF and M-CSF Induces Human Macrophages toward an Inflammatory Protumor Phenotype
- (2020) Léa Paolini et al. Cancer Immunology Research
- Tumour immune cell infiltration and survival after platinum-based chemotherapy in high-grade serous ovarian cancer subtypes: A gene expression-based computational study
- (2020) Rong Liu et al. EBioMedicine
- Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents
- (2020) Paola Ciciola et al. Journal of Clinical Medicine
- Metabolic Plasticity in Chemotherapy Resistance
- (2020) Maria Andrea Desbats et al. Frontiers in Oncology
- Metabolic factors contribute to T‐cell inhibition in the ovarian cancer ascites
- (2020) Yueqing Gong et al. INTERNATIONAL JOURNAL OF CANCER
- The Ovarian Cancer Tumor Immune Microenvironment (TIME) as Target for Therapy: A Focus on Innate Immunity Cells as Therapeutic Effectors
- (2020) Denisa Baci et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Distinct fibroblast functional states drive clinical outcomes in ovarian cancer and are regulated by TCF21
- (2020) Ali Hussain et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting Fatty Acid Oxidation to Promote Anoikis and Inhibit Ovarian Cancer Progression
- (2020) Brandon T. Sawyer et al. MOLECULAR CANCER RESEARCH
- Single-cell EMT-related transcriptional analysis revealed intra-cluster heterogeneity of tumor cell clusters in epithelial ovarian cancer ascites
- (2020) Tongtong Kan et al. ONCOGENE
- Inhibition of collagen XI alpha 1-induced fatty acid oxidation triggers apoptotic cell death in cisplatin-resistant ovarian cancer
- (2020) Sameera Nallanthighal et al. Cell Death & Disease
- Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients
- (2020) Antonio Macciò et al. Scientific Reports
- Flow-induced Shear Stress Confers Resistance to Carboplatin in an Adherent Three-Dimensional Model for Ovarian Cancer: A Role for EGFR-Targeted Photoimmunotherapy Informed by Physical Stress
- (2020) Shubhankar Nath et al. Journal of Clinical Medicine
- Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma
- (2020) Tashbib Khan et al. Cancers
- Exploring the potential of engineered exosomes as delivery systems for tumor-suppressor microRNA replacement therapy in ovarian cancer
- (2020) Masaki Kobayashi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tumor associated macrophages in the molecular pathogenesis of ovarian cancer
- (2020) Yousef Yousefzadeh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer
- (2020) Jason R Brown et al. JCI Insight
- Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer
- (2019) Edith Emmings et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor
- (2019) Allison Gartung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma
- (2019) Yanxia Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis
- (2019) Cristian Rodriguez-Aguayo et al. EBioMedicine
- Platinum Resistance in Ovarian Cancer: Role of DNA Repair
- (2019) Giovanna Damia et al. Cancers
- A Pan-ALDH1A Inhibitor Induces Necroptosis in Ovarian Cancer Stem-like Cells
- (2019) Ilana Chefetz et al. Cell Reports
- Niraparib activates interferon signaling and potentiates anti-PD-1 antibody efficacy in tumor models
- (2019) Zebin Wang et al. Scientific Reports
- Reversing platinum resistance in ovarian cancer multicellular spheroids by targeting Bcl-2
- (2019) Ya'nan Yang et al. OncoTargets and Therapy
- Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways
- (2019) Dongya Jia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Deprivation of glutamine in cell culture reveals its potential for treating cancer
- (2019) Harry Rubin PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response
- (2019) Camilla Salvagno et al. NATURE CELL BIOLOGY
- Epithelial ovarian cancer
- (2019) Stephanie Lheureux et al. LANCET
- Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer
- (2019) Qinglei Gao et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype
- (2019) Xiaolan Zhu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers
- (2019) Branimir I. Sikic et al. JOURNAL OF CLINICAL ONCOLOGY
- Fatty Acid Synthesis and Degradation Interplay to Regulate the Oxidative Stress in Cancer Cells
- (2019) Valeryia Mikalayeva et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Depletion of tumor-associated macrophages enhances the anti-tumor effect of docetaxel in a murine epithelial ovarian cancer
- (2019) Xiaofen Lu et al. IMMUNOBIOLOGY
- Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression
- (2019) Pieter Goossens et al. Cell Metabolism
- DFMO and 5-azacytidine increase M1 macrophages in the tumor microenvironment of murine ovarian cancer.
- (2019) Meghan Travers et al. CANCER RESEARCH
- The metastatic phenotype shift toward myofibroblast of adipose-derived mesenchymal stem cells promotes ovarian cancer progression
- (2019) Huijuan Tang et al. CARCINOGENESIS
- Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype
- (2019) Masataka Takenaka et al. CLINICAL CANCER RESEARCH
- ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
- (2019) N Colombo et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts
- (2019) Mark A. Eckert et al. NATURE
- An allosteric mechanism for potent inhibition of human ATP-citrate lyase
- (2019) Jia Wei et al. NATURE
- Interaction of tumor-associated macrophages and cancer chemotherapy
- (2019) Irina Larionova et al. OncoImmunology
- USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability
- (2019) Maura Sonego et al. Science Advances
- NKX2-8 deletion-induced reprogramming of fatty acid metabolism confers chemoresistance in epithelial ovarian cancer
- (2019) Jinrong Zhu et al. EBioMedicine
- A Novel ALDH1A1 Inhibitor Targets Cells with Stem Cell Characteristics in Ovarian Cancer
- (2019) Nkechiyere Nwani et al. Cancers
- Macrophage Polarization in the Development and Progression of Ovarian Cancers: An Overview
- (2019) Huiyan Cheng et al. Frontiers in Oncology
- Cancer-associated fibroblasts—heroes or villains?
- (2019) Krystyna A. Gieniec et al. BRITISH JOURNAL OF CANCER
- Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
- (2019) Denarda Dangaj et al. CANCER CELL
- Steroyl-CoA Desaturase 1 (SCD1) protects ovarian cancer cells from ferroptotic cell death
- (2019) Lia Tesfay et al. CANCER RESEARCH
- CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
- (2019) Amira A. Barkal et al. NATURE
- Targeting metabolism to regulate immune responses in autoimmunity and cancer
- (2019) Chirag H. Patel et al. NATURE REVIEWS DRUG DISCOVERY
- Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer
- (2019) Thaïs Baert et al. Frontiers in Immunology
- Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer
- (2019) Els Van Nieuwenhuysen et al. NEOPLASIA
- Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments
- (2019) Shreya Raghavan et al. Journal for ImmunoTherapy of Cancer
- The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
- (2019) Nele Loret et al. Cancers
- Ovarian Cancer Stemness: Biological and Clinical Implications for Metastasis and Chemotherapy Resistance
- (2019) Takeshi Motohara et al. Cancers
- Rare Distant Metastatic Disease of Ovarian and Peritoneal Carcinomatosis: A Review of the Literature
- (2019) Nikolaos Thomakos et al. Cancers
- A Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas
- (2019) Philip A Philip et al. Future Oncology
- A phase 1b dose escalation study of ipafricept (OMP 54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer
- (2019) Kathleen N. Moore et al. GYNECOLOGIC ONCOLOGY
- Management of Rare Ovarian Cancer Histologies
- (2019) David M. Gershenson et al. JOURNAL OF CLINICAL ONCOLOGY
- Ovarian primary and metastatic tumors suppressed by survivin knockout or a novel survivin inhibitor
- (2019) Guannan Zhao et al. MOLECULAR CANCER THERAPEUTICS
- Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target
- (2019) Koji Nakamura et al. Cancers
- Targeted activation of Stat3 in combination with paclitaxel results in increased apoptosis in epithelial ovarian cancer cells and a reduced tumour burden
- (2019) Hongyi Li et al. CELL PROLIFERATION
- Wnt Signaling in Ovarian Cancer Stemness, EMT, and Therapy Resistance
- (2019) Teeuwssen et al. Journal of Clinical Medicine
- Ovarian Cancer—Why Lipids Matter
- (2019) Guangyuan Zhao et al. Cancers
- The Metabolic Inhibitor CPI-613 Negates Treatment Enrichment of Ovarian Cancer Stem Cells
- (2019) Chiara Bellio et al. Cancers
- Immunotherapy with checkpoint inhibitors in patients with ovarian cancer: Still promising?
- (2019) Antonio González‐Martín et al. CANCER
- The Impact of Stroma Admixture on Molecular Subtypes and Prognostic Gene Signatures in Serous Ovarian Cancer
- (2019) Matthew Schwede et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- EMR 20006-012: A phase II randomized double-blind placebo controlled trial comparing the combination of pimasertib (MEK inhibitor) with SAR245409 (PI3K inhibitor) to pimasertib alone in patients with previously treated unresectable borderline or low grade ovarian cancer
- (2019) Rebecca C. Arend et al. GYNECOLOGIC ONCOLOGY
- ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors
- (2019) Katja Kaipio et al. JOURNAL OF PATHOLOGY
- Ovarian cancer stem cells and targeted therapy
- (2019) Vahideh Keyvani et al. Journal of Ovarian Research
- Platinum Derivatives Effects on Anticancer Immune Response
- (2019) Cédric Rébé et al. Biomolecules
- Licofelone enhances the efficacy of paclitaxel in ovarian cancer by reversing drug resistance and tumor stem-like properties
- (2018) Jeff Hirst et al. CANCER RESEARCH
- A Novel TGFβ Trap Blocks Chemotherapeutics-Induced TGFβ1 Signaling and Enhances Their Anticancer Activity in Gynecologic Cancers
- (2018) Haiyan Zhu et al. CLINICAL CANCER RESEARCH
- Trabectedin in Ovarian Cancer: is it now a Standard of Care?
- (2018) J. Ventriglia et al. CLINICAL ONCOLOGY
- Metabolic vulnerability of cisplatin‐resistant cancers
- (2018) Florine Obrist et al. EMBO JOURNAL
- Phase IB dose escalation and expansion trial of the oral hedgehog inhibitor sonidegib (LDE225) and weekly paclitaxel in platinum-resistant ovarian cancer (NCT02195973)
- (2018) R.C. Arend et al. GYNECOLOGIC ONCOLOGY
- Tumor associated macrophages in gynecologic cancers
- (2018) Venkatesh Krishnan et al. GYNECOLOGIC ONCOLOGY
- The effect of FASN inhibition on the growth and metabolism of a cisplatin-resistant ovarian carcinoma model
- (2018) Efthymia Papaevangelou et al. INTERNATIONAL JOURNAL OF CANCER
- Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System
- (2018) Christina Wefers et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
- (2018) Heng Lin et al. JOURNAL OF CLINICAL INVESTIGATION
- Emerging role of lipid metabolism alterations in Cancer stem cells
- (2018) Mei Yi et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
- (2018) Lauren C Peres et al. JNCI-Journal of the National Cancer Institute
- Systematic Identification of Druggable Epithelial–Stromal Crosstalk Signaling Networks in Ovarian Cancer
- (2018) Tsz-Lun Yeung et al. JNCI-Journal of the National Cancer Institute
- Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer
- (2018) Sara Al Habyan et al. ONCOGENE
- Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis
- (2018) Andras Ladanyi et al. ONCOGENE
- Advances of exosome in the development of ovarian cancer and its diagnostic and therapeutic prospect
- (2018) Jiayu Shen et al. OncoTargets and Therapy
- miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
- (2018) Anne-Marie Givel et al. Nature Communications
- DNA damage repair in ovarian cancer: unlocking the heterogeneity
- (2018) Mary Ellen Gee et al. Journal of Ovarian Research
- Protein expression patterns in cancer-associated fibroblasts and cells undergoing the epithelial-mesenchymal transition in ovarian cancers
- (2018) Daisuke Fukagawa et al. Oncotarget
- Ferroptosis: A Novel Anti-tumor Action for Cisplatin
- (2018) Jipeng Guo et al. Cancer Research and Treatment
- Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage
- (2018) Lauren C Peres et al. JNCI-Journal of the National Cancer Institute
- Systematic Identification of Druggable Epithelial–Stromal Crosstalk Signaling Networks in Ovarian Cancer
- (2018) Tsz-Lun Yeung et al. JNCI-Journal of the National Cancer Institute
- Blocking LPA-dependent signaling increases ovarian cancer cell death in response to chemotherapy
- (2018) LeAnn C. Rogers et al. Redox Biology
- Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease
- (2018) Michael M. Boyiadzis et al. Journal for ImmunoTherapy of Cancer
- Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype
- (2018) Xin Chen et al. CANCER LETTERS
- Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis
- (2018) Marion Curtis et al. Cell Metabolism
- Association of TGF-β responsive signature with anti-tumor effect of vactosertib, a potent, oral TGF-β receptor type I (TGFBRI) inhibitor in patients with advanced solid tumors.
- (2018) Vicki Leigh Keedy et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I study of AL101, a pan-NOTCH inhibitor, in patients (pts) with locally advanced or metastatic solid tumors.
- (2018) Anthony B. El-Khoueiry et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrated eicosanoid lipidomics and gene expression reveal decreased prostaglandin catabolism and increased 5-lipoxygenase expression in aggressive subtypes of endometrial cancer
- (2018) Michele Cummings et al. JOURNAL OF PATHOLOGY
- PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness
- (2018) Jianfeng Shen et al. CANCER RESEARCH
- Review of Immune Therapies Targeting Ovarian Cancer
- (2018) Cong Fan et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Novel treatment options in platinum-sensitive recurrent ovarian cancer: A review
- (2018) Mary M. Mullen et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer stem cells and their role in drug resistance
- (2018) Zalitha Pieterse et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum
- (2018) WonJae Lee et al. JOURNAL OF EXPERIMENTAL MEDICINE
- PARP inhibition induces enrichment of DNA repair proficient CD133 and CD117 positive ovarian cancer stem cells
- (2018) Chiara Bellio et al. MOLECULAR CANCER RESEARCH
- Cell type-selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment
- (2018) Silke Reinartz et al. Molecular Oncology
- Molecular Repolarisation of Tumour-Associated Macrophages
- (2018) Floris van Dalen et al. MOLECULES
- IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity
- (2018) Minkyung Song et al. NATURE
- Targeting macrophages: therapeutic approaches in cancer
- (2018) Luca Cassetta et al. NATURE REVIEWS DRUG DISCOVERY
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment
- (2018) Takeshi Motohara et al. ONCOGENE
- Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth
- (2018) Karen McLean et al. ONCOGENE
- Ovarian Carcinoma-Associated Mesenchymal Stem Cells Arise from Tissue-Specific Normal Stroma
- (2018) Lan G. Coffman et al. STEM CELLS
- CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer
- (2018) Lindsay J. Wheeler et al. Oncogenesis
- Cancer Associated Fibroblasts: Naughty Neighbors That Drive Ovarian Cancer Progression
- (2018) Subramanyam Dasari et al. Cancers
- PARP inhibitors in ovarian cancer
- (2018) Elisena Franzese et al. CANCER TREATMENT REVIEWS
- Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts
- (2018) Rangasudhagar Radhakrishnan et al. CANCER LETTERS
- Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis
- (2017) Xia Yuan et al. GYNECOLOGIC ONCOLOGY
- Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance
- (2017) Cecilia S. Leung et al. JOURNAL OF CLINICAL INVESTIGATION
- Glutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and VHL-deficient renal cancers
- (2017) Arimichi Okazaki et al. JOURNAL OF CLINICAL INVESTIGATION
- Somatic BRCA1/2 Recovery as a Resistance Mechanism After Exceptional Response to Poly (ADP-ribose) Polymerase Inhibition
- (2017) Stephanie Lheureux et al. JOURNAL OF CLINICAL ONCOLOGY
- Carboplatin and programmed death-ligand 1 blockade synergistically produce a similar antitumor effect to carboplatin alone in murine ID8 ovarian cancer model
- (2017) Xinxin Zhu et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer
- (2017) Angela Rynne-Vidal et al. JOURNAL OF PATHOLOGY
- Mesenchymal stem cells: key players in cancer progression
- (2017) Sarah M. Ridge et al. Molecular Cancer
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes
- (2017) Yi Kan Wang et al. NATURE GENETICS
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- An integrated analysis identifies STAT4 as a key regulator of ovarian cancer metastasis
- (2017) L Zhao et al. ONCOGENE
- Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization
- (2017) Xin Chen et al. ONCOLOGY REPORTS
- Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development
- (2017) Lindsay Wilde et al. SEMINARS IN ONCOLOGY
- Immunological Functions of the Omentum
- (2017) Selene Meza-Perez et al. TRENDS IN IMMUNOLOGY
- Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells
- (2017) Anna Pagotto et al. Cell Death & Disease
- Dual inhibition of glycolysis and glutaminolysis as a therapeutic strategy in the treatment of ovarian cancer
- (2017) Li Sun et al. Oncotarget
- Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy
- (2017) Yasmin A. Lyons et al. Oncotarget
- TGFβ1 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells
- (2017) Wenqian Li et al. Oncotarget
- CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis
- (2017) Ran Liu et al. Oncotarget
- Clear cell ovarian cancers with microsatellite instability: A unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1/PD-L1 expression
- (2017) Brooke E. Howitt et al. OncoImmunology
- The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
- (2017) Thomas Worzfeld et al. Frontiers in Oncology
- Bioenergetic Adaptations in Chemoresistant Ovarian Cancer Cells
- (2017) Sajad Dar et al. Scientific Reports
- CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity
- (2017) Josephine B. Walton et al. Scientific Reports
- The Dualistic Model of Ovarian Carcinogenesis
- (2016) Robert J. Kurman et al. AMERICAN JOURNAL OF PATHOLOGY
- BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer
- (2016) M. Moschetta et al. ANNALS OF ONCOLOGY
- The Warburg effect: 80 years on
- (2016) Michelle Potter et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche
- (2016) Fabrizio Miranda et al. CANCER CELL
- Ovarian Cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor PBX1
- (2016) Jin-Gyoung Jung et al. CANCER RESEARCH
- Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer
- (2016) Soochi Kim et al. CANCER SCIENCE
- Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer
- (2016) Weimin Wang et al. CELL
- Metabolic Heterogeneity in Human Lung Tumors
- (2016) Christopher T. Hensley et al. CELL
- Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer
- (2016) D S Matassa et al. CELL DEATH AND DIFFERENTIATION
- Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions
- (2016) Isabelle Matte et al. CLINICAL & EXPERIMENTAL METASTASIS
- Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy
- (2016) Charlotte S. Lo et al. CLINICAL CANCER RESEARCH
- A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer
- (2016) Shubham Pant et al. EUROPEAN JOURNAL OF CANCER
- Preclinical evaluation of olaparib and metformin combination in BRCA1 wildtype ovarian cancer
- (2016) M. Hijaz et al. GYNECOLOGIC ONCOLOGY
- Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways
- (2016) BO ZHOU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The impact of hypoxia on tumor-associated macrophages
- (2016) Anne-Theres Henze et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer
- (2016) Mingzhu Yin et al. JOURNAL OF CLINICAL INVESTIGATION
- Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives
- (2016) Seiji Mabuchi et al. Journal of Gynecologic Oncology
- Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapy
- (2016) Christos E. Zois et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Discovery of tumor-specific irreversible inhibitors of stearoyl CoA desaturase
- (2016) Panayotis C Theodoropoulos et al. Nature Chemical Biology
- Blockage of glutaminolysis enhances the sensitivity of ovarian cancer cells to PI3K/mTOR inhibition involvement of STAT3 signaling
- (2016) Lili Guo et al. TUMOR BIOLOGY
- Milky spots: omental functional units and hotbeds for peritoneal cancer metastasis
- (2016) Jiuyang Liu et al. TUMOR BIOLOGY
- Amplification of USP13 drives ovarian cancer metabolism
- (2016) Cecil Han et al. Nature Communications
- Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
- (2016) Chi Lam Au Yeung et al. Nature Communications
- Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gαi2, Src, and HIF1α signaling nexus
- (2016) Ji Hee Ha et al. Oncotarget
- The association between copper transporters and the prognosis of cancer patients undergoing chemotherapy: a meta-analysis of literatures and datasets
- (2016) Si Sun et al. Oncotarget
- Human carcinoma-associated mesenchymal stem cells promote ovarian cancer chemotherapy resistance via a BMP4/HH signaling loop
- (2016) Lan G. Coffman et al. Oncotarget
- Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
- (2016) Junli Deng et al. Oncotarget
- Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer
- (2016) Koji Yamanoi et al. Oncotarget
- Hypoxia-NOTCH1-SOX2 signaling is important for maintaining cancer stem cells in ovarian cancer
- (2016) Eun Jin Seo et al. Oncotarget
- Resistance to glucose starvation as metabolic trait of platinum-resistant human epithelial ovarian cancer cells
- (2016) Anna Pastò et al. Oncotarget
- Altered glutamine metabolism in platinum resistant ovarian cancer
- (2016) Chantelle D. Hudson et al. Oncotarget
- MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4
- (2016) Candice Sun Hong et al. Cell Reports
- Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy
- (2016) Wanyin Chen et al. Stem Cells International
- Cisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian Tumors
- (2016) Winyoo Chowanadisai et al. PLoS One
- Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress
- (2016) Carman K. M. Ip et al. Scientific Reports
- Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers
- (2015) Denis Lane et al. BMC CANCER
- Macrophage Blockade Using CSF1R Inhibitors Reverses the Vascular Leakage Underlying Malignant Ascites in Late-Stage Epithelial Ovarian Cancer
- (2015) D. L. Moughon et al. CANCER RESEARCH
- Upregulation of Periostin and Reactive Stroma Is Associated with Primary Chemoresistance and Predicts Clinical Outcomes in Epithelial Ovarian Cancer
- (2015) L. Ryner et al. CLINICAL CANCER RESEARCH
- CD44 Isoform Status Predicts Response to Treatment with Anti-CD44 Antibody in Cancer Patients
- (2015) F. Birzele et al. CLINICAL CANCER RESEARCH
- A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia
- (2015) Ivan Diaz-Padilla et al. GYNECOLOGIC ONCOLOGY
- Updates and emerging therapies for rare epithelial ovarian cancers: One size no longer fits all
- (2015) Reinou S. Groen et al. GYNECOLOGIC ONCOLOGY
- 2-Deoxy-d-Glucose Sensitizes Human Ovarian Cancer Cells to Cisplatin by Increasing ER Stress and Decreasing ATP Stores in Acidic Vesicles
- (2015) Lili Zhang et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- M-Trap: Exosome-Based Capture of Tumor Cells as a New Technology in Peritoneal Metastasis
- (2015) Alexandre de la Fuente et al. JNCI-Journal of the National Cancer Institute
- Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer
- (2015) Dirk O Bauerschlag et al. Journal of Translational Medicine
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells
- (2015) Amit Kumar Srivastava et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HNF1β drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC)
- (2015) Filipa Lopes-Coelho et al. TUMOR BIOLOGY
- An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer
- (2015) D. M. Janzen et al. Nature Communications
- Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer
- (2015) P. A. Konstantinopoulos et al. Cancer Discovery
- Inhibition of glucose-6-phosphate dehydrogenase sensitizes cisplatin-resistant cells to death
- (2015) Daniela Catanzaro et al. Oncotarget
- Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival
- (2015) Yasuaki Amano et al. Oncotarget
- Ovarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reduction
- (2015) Masaki Mandai et al. Oncotarget
- M-Trap: Exosome-Based Capture of Tumor Cells as a New Technology in Peritoneal Metastasis
- (2015) Alexandre de la Fuente et al. JNCI-Journal of the National Cancer Institute
- The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
- (2015) Leisha A. Emens et al. Cancer Immunology Research
- Inhibition of de novo Palmitate Synthesis by Fatty Acid Synthase Induces Apoptosis in Tumor Cells by Remodeling Cell Membranes, Inhibiting Signaling Pathways, and Reprogramming Gene Expression
- (2015) Richard Ventura et al. EBioMedicine
- Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells
- (2015) Lihong Mo et al. PLoS One
- Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation
- (2015) Anna Pastò et al. Oncotarget
- Cancer-Associated Fibroblasts and Their Putative Role in Potentiating the Initiation and Development of Epithelial Ovarian Cancer
- (2015) Isaiah G. Schauer et al. NEOPLASIA
- The Role of Mechanical Forces in Tumor Growth and Therapy
- (2014) Rakesh K. Jain et al. Annual Review of Biomedical Engineering
- Metabolic orchestration between cancer cells and tumor microenvironment as a co-evolutionary source of chemoresistance in ovarian cancer: A therapeutic implication
- (2014) Dong Hoon Suh et al. BIOCHEMICAL PHARMACOLOGY
- Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response
- (2014) S R McKeown BRITISH JOURNAL OF RADIOLOGY
- Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread
- (2014) Sunila Pradeep et al. CANCER CELL
- 2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy
- (2014) Dongsheng Zhang et al. CANCER LETTERS
- Catumaxomab for the Treatment of Malignant Ascites in Patients With Chemotherapy-Refractory Ovarian Cancer
- (2014) Jonathan S. Berek et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion
- (2014) Hilary A. Kenny et al. JOURNAL OF CLINICAL INVESTIGATION
- Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer
- (2014) Gottfried E. Konecny et al. JNCI-Journal of the National Cancer Institute
- Down-regulation of Ras-related Protein Rab 5C-dependent Endocytosis and Glycolysis in Cisplatin-resistant Ovarian Cancer Cell Lines
- (2014) Lixu Jin et al. MOLECULAR & CELLULAR PROTEOMICS
- Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors
- (2014) Elisa Gomez Perdiguero et al. NATURE
- Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
- (2014) Oscar R. Colegio et al. NATURE
- Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration
- (2014) Z Wen et al. ONCOGENE
- Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism
- (2014) Jianqun Liao et al. PLoS One
- Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes
- (2014) Corine M. Beaufort et al. PLoS One
- Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study
- (2014) Irene Brana et al. Targeted Oncology
- Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
- (2014) William W Wheaton et al. eLife
- Milky Spots Promote Ovarian Cancer Metastatic Colonization of Peritoneal Adipose in Experimental Models
- (2013) Robert Clark et al. AMERICAN JOURNAL OF PATHOLOGY
- Expression of the Homeobox Gene HOXA9 in Ovarian Cancer Induces Peritoneal Macrophages to Acquire an M2 Tumor-Promoting Phenotype
- (2013) Song Yi Ko et al. AMERICAN JOURNAL OF PATHOLOGY
- Impact of 2-deoxy-D-glucose on the target metabolome profile of a human endometrial cancer cell line
- (2013) Kenichi URAKAMI et al. BIOMEDICAL RESEARCH-TOKYO
- Role of Macrophage Targeting in the Antitumor Activity of Trabectedin
- (2013) Giovanni Germano et al. CANCER CELL
- Macrophage Regulation of Tumor Responses to Anticancer Therapies
- (2013) Michele De Palma et al. CANCER CELL
- A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
- (2013) Shahneen K. Sandhu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment
- (2013) E. M. Dijkgraaf et al. CANCER RESEARCH
- TGF- Modulates Ovarian Cancer Invasion by Upregulating CAF-Derived Versican in the Tumor Microenvironment
- (2013) T.-L. Yeung et al. CANCER RESEARCH
- Activity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer
- (2013) R. Polanski et al. CLINICAL CANCER RESEARCH
- Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancer
- (2013) Pierre-Emmanuel Colombo et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Loss of DOK2 induces carboplatin resistance in ovarian cancer via suppression of apoptosis
- (2013) Elena Lum et al. GYNECOLOGIC ONCOLOGY
- Notch3 induces epithelial–mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells
- (2013) Nidhi Gupta et al. GYNECOLOGIC ONCOLOGY
- Mismatch repair deficiency in ovarian cancer — Molecular characteristics and clinical implications
- (2013) Xue Xiao et al. GYNECOLOGIC ONCOLOGY
- Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts
- (2013) Tat-San Lau et al. JOURNAL OF PATHOLOGY
- Carcinoma-associated fibroblasts derive from mesothelial cells via mesothelial-to-mesenchymal transition in peritoneal metastasis
- (2013) Pilar Sandoval et al. JOURNAL OF PATHOLOGY
- Hepatocyte nuclear factor-1β (HNF-1β) promotes glucose uptake and glycolytic activity in ovarian clear cell carcinoma
- (2013) Takako Okamoto et al. MOLECULAR CARCINOGENESIS
- Correction: Type-Specific Cell Line Models for Type-Specific Ovarian Cancer Research
- (2013) Michael S. Anglesio et al. PLoS One
- Human Omental-Derived Adipose Stem Cells Increase Ovarian Cancer Proliferation, Migration, and Chemoresistance
- (2013) Aleksandra Nowicka et al. PLoS One
- Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules
- (2013) I. Rizvi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluating cell lines as tumour models by comparison of genomic profiles
- (2013) Silvia Domcke et al. Nature Communications
- Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research
- (2013) Nuzhat Ahmed et al. Frontiers in Oncology
- The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells
- (2012) Dongming Liang et al. BMC CANCER
- EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
- (2012) Alexandria M Haslehurst et al. BMC CANCER
- Repeated cisplatin treatment can lead to a multiresistant tumor cell population with stem cell features and sensitivity to 3-bromopyruvate
- (2012) My Wintzell et al. CANCER BIOLOGY & THERAPY
- A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors
- (2012) Luis E. Raez et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Hereditary ovarian cancer and two-compartment tumor metabolism
- (2012) Ubaldo E. Martinez-Outschoorn et al. CELL CYCLE
- A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission
- (2012) S. B. Kaye et al. CLINICAL CANCER RESEARCH
- Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies
- (2012) D. Mahadevan et al. EUROPEAN JOURNAL OF CANCER
- Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer
- (2012) Sergio Marchini et al. EUROPEAN JOURNAL OF CANCER
- VEGF induces ascites in ovarian cancer patients via increasing peritoneal permeability by downregulation of Claudin 5
- (2012) Daniel Herr et al. GYNECOLOGIC ONCOLOGY
- Metformin targets ovarian cancer stem cells in vitro and in vivo
- (2012) Jessica J. Shank et al. GYNECOLOGIC ONCOLOGY
- Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2
- (2012) Sharon Cohen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies
- (2012) Celeste Leigh Pearce et al. LANCET ONCOLOGY
- AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress
- (2012) Sang-Min Jeon et al. NATURE
- c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin–ATP-binding cassette G2 signaling
- (2012) W K Chau et al. ONCOGENE
- MicroRNAs Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts in Ovarian Cancer
- (2012) A. K. Mitra et al. Cancer Discovery
- Aldehyde Dehydrogenase in Combination with CD133 Defines Angiogenic Ovarian Cancer Stem Cells That Portend Poor Patient Survival
- (2011) I. A. Silva et al. CANCER RESEARCH
- Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness
- (2011) J. Cai et al. CARCINOGENESIS
- Autocrine production of interleukin-8 confers cisplatin and paclitaxel resistance in ovarian cancer cells
- (2011) Yue Wang et al. CYTOKINE
- Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production
- (2011) Karen McLean et al. JOURNAL OF CLINICAL INVESTIGATION
- Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas
- (2011) Barbara Norquist et al. JOURNAL OF CLINICAL ONCOLOGY
- Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma
- (2011) Atsuko Katagiri et al. MODERN PATHOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
- (2011) Kristin M Nieman et al. NATURE MEDICINE
- Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells
- (2011) P Yue et al. ONCOGENE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- SIK2 Is a Centrosome Kinase Required for Bipolar Mitotic Spindle Formation that Provides a Potential Target for Therapy in Ovarian Cancer
- (2010) Ahmed Ashour Ahmed et al. CANCER CELL
- Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells
- (2010) Yue Wang et al. CANCER LETTERS
- Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression
- (2010) Hongmin Chen et al. CLINICAL & EXPERIMENTAL METASTASIS
- Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
- (2010) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells
- (2010) Shelley B Hooks et al. Molecular Cancer
- ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
- (2010) Kimberly C. Wiegand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ovarian cancer ascites protects from TRAIL-induced cell death through αvβ5 integrin-mediated focal adhesion kinase and Akt activation
- (2010) D Lane et al. ONCOGENE
- Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies
- (2010) Mark Stein et al. PROSTATE
- Ovarian carcinoma cells with low levels of -F1-ATPase are sensitive to combined platinum and 2-deoxy-D-glucose treatment
- (2009) E. Hernlund et al. MOLECULAR CANCER THERAPEUTICS
- Endometrioid epithelial ovarian cancer
- (2008) Dawn J. Storey et al. CANCER
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now